Lorant Leopold

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

José Valdez Madruga, Pedro Cahn, Beatriz Grinsztejn et al. · The Lancet · 2007 · 516 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial

Robert W. Finberg, Riin Lanno, David Anderson et al. · The Journal of Infectious Diseases · 2018 · 132 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Pimodivir Treatment in Adult Volunteers Experimentally Inoculated with Live Influenza Virus: A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study

José Trevejo, Mohammed Asmal, Johan Vingerhoets et al. · Antiviral Therapy · 2017 · 56 citations

Medicine, Infectious Diseases, Pharmacology +17

Pharmacokinetics and Pharmacodynamics of the Non-Nucleoside Reverse-Transcriptase Inhibitor Etravirine in Treatment-Experienced HIV-1-Infected Patients

Thomas N. Kakuda, Janet R. Wade, Eric Snoeck et al. · Clinical Pharmacology & Therapeutics · 2010 · 50 citations

Medicine, Pharmacokinetics, Pharmacology +17

A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study

Brian J. O’Neil, Michael G. Ison, Marie Charlotte Hallouin-Bernard et al. · The Journal of Infectious Diseases · 2020 · 32 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14